Dr. Thomas Lee Holden, MD

Dr. Holden practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Holden's NPI, 1679968218, was assigned on March 31, 2015. Dr. Holden graduated from OU College of Medicine in 2015. Dr. Holden holds California license A177323.

Dr. Holden's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Holden's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Holden to 1 more hospital and 1 medical group, each named with a free account. Dr. Holden's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holden practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Holden's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Holden is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Holden's licenses on file in 3 states: California, Pennsylvania and Ohio.

Dmand AI lists breast cancer, colorectal cancer, lung cancer and lymphoma among the conditions Dr. Holden treats.

CMS data shows 770 Medicare services from Dr. Holden across 7 procedure codes in 2024, for 182 Medicare patients. Medicare paid $83,425 for them.

CMS counts 182 Medicare patients who saw Dr. Holden in 2024. The largest group is 65 to 74, with 81 patients. 74% of them have high blood pressure, and 69% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Holden's median patient age at 62, with 44% women.

In 2024, Dr. Holden wrote 117 Medicare Part D claims for 36 patients. 89% of them were for generic drugs. CMS names the drug for 44 of them, across 2 drugs with 11 or more claims each, at $349 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Holden for performance year 2024, reported as part of a group. Dr. Holden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holden as offering telehealth.

Dmand AI links 5 papers to Dr. Holden, published from 2016 to 2025. The most frequent topics are Emotions, Face and Facial Expression. Dr. Holden has published most often in Cortex. Dr. Holden's most frequent co-authors are Michael John Hall, ND, Elliott D. Ross, MD and Jeffrey Bien, MD.

CMS Open Payments shows 3 general payments to Dr. Holden from 3 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 98% of the total. Bristol-Myers Squibb Company paid the most, $1,620.

Dmand AI lists 1 award for Dr. Holden, most recently Phi Kappa Phi in 2014.

Dr. Holden graduated from OU College of Medicine in 2015. Dr. Holden is a member of ASCO and ASH.

Dr. Holden is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.